The city’s new Medical Devices Commercialization Centre has appointed Richard Meadows as its first chief operating officer, the centre announced on Wednesday.
Mr. Meadows comes to the centre with experience in commercialization of medical devices in the biopharmaceutical industry, including stints with major companies such as Bristol Myers and Procter & Gamble.
He was CEO of DERMACOR, the first wound care company in Canada, and most recently has been involved with venture capital firms investing in the life sciences sector.
(Sponsored)
Invest with confidence: Hydro Ottawa funds technical studies for business retrofits
For Ottawa businesses, the opportunity to improve building performance has never been greater. Energy retrofits can cut emissions, strengthen operations, extend the life of assets, reduce operating costs, and position
Family-owned Coke Canada Bottling investing to grow in Ottawa-Gatineau
Have you ever wondered where your favourite Coca-Cola products come from? Few people in know that over 300 popular beverages products, like Coca-Cola, Coke Zero, Fuze, Fanta, Monster Energy, A&W
In 2013, Forbes magazine recognized Mr. Meadows, who co-founded the CTI Life Sciences Fund, as one of the top 10 life sciences investors in North America.
